US equities |
TSLA $391.62 ▲+5.21% MU $903.70 ▲+2.98% META $630.56 ▼-1.88% NVDA $216.00 ▲+2.39% AAPL $343.91 ▼-1.10% SPCX $146.90 ▼-0.40% MSFT $532.60 ▲+1.54% AMD $531.28 ▲+2.80%
FinancialContent

Progyny, Inc. - Common Stock (NQ:PGNY)

28.13 -0.84 (-2.90%)
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
Progyny COO Cummings Sells 3,437 Shares for $109,000 -- Here's What That Means for Investors ↗
Disposition reduced her direct holdings by 5% through a combination of Rule 10b5-1 plan sales and tax-withholding shares, leaving her with a $2.26 million stake. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Cash-Producing Stock with Competitive Advantages and 2 Facing Challenges
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's
Check out the companies making headlines yesterday: RXO (NYSE:RXO): Freight Delivery Company RXO (NYSE:RXO) rose by 4.2% on Monday after Stifel raised its pr... 
Via StockStory
News headline image
3 Small-Cap Stocks with Warning Signs
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
Topics Electric Vehicles
Progyny Inc (NASDAQ:PGNY) Offers Affordable Growth With Strong Fundamentals ↗
Via Chartmill
Progyny Inc (NASDAQ:PGNY) Screens Well on Caviar Cruise Quality Investing Metrics ↗
Via Chartmill
Progynyn (NASDAQ:PGNY): A Bull Flag Breakout with Strong Fundamentals ↗
Via Chartmill
News headline image
Progyny (PGNY) Stock Is Up, What You Need To Know
What Happened? Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.5% in the afternoon session after KeyBanc raised its price target on the s... 
Via StockStory
News headline image
Progyny (PGNY): Buy, Sell, or Hold Post Q1 Earnings?
Progyny trades at $31.10 per share and has stayed right on track with the overall market, gaining 13.4% over the last six months. At the same time, the S&P 5... 
Via StockStory
Topics Stocks Supply Chain
News headline image
3 Value Stocks That Fall Short
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
What Does the Sale of Progyny Shares by the CFO Mean for Investors? ↗
Progyny delivers fertility benefits to employers nationwide; a key insider recently trimmed their stake, according to SEC filings. 
Via The Motley Fool
Topics Regulatory Compliance
Progyny Inc (NASDAQ:PGNY): A GARP Play with Balanced Growth and Valuation ↗
Via Chartmill
Progyny Inc (NASDAQ:PGNY) Beats Q1 Estimates and Guides Above Consensus as Selling Season Off to a Strong Start ↗
Via Chartmill
News headline image
1 Russell 2000 Stock for Long-Term Investors and 2 We Turn Down
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
News headline image
3 Cash-Heavy Stocks That Concern Us
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c... 
Via StockStory
News headline image
A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000 ↗
Progyny delivers fertility benefits to major employers; a key insider recently trimmed their stake, according to SEC filings. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System
Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience 
From Progyny, Inc.
Via GlobeNewswire
News headline image
Progyny, Inc. Announces Share Repurchase Program
From Progyny, Inc.
Via GlobeNewswire
News headline image
3 Stocks Under $50 with Warning Signs
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
Topics Retirement Supply Chain
News headline image
Progyny (PGNY) Stock Is Up, What You Need To Know
What Happened? Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 2.4% in the afternoon session after Canaccord Genuity upgraded the company's... 
Via StockStory
News headline image
Progyny’s Q1 Earnings Call: Our Top 5 Analyst Questions
Progyny’s first quarter was met with a positive market response, driven by revenue and non-GAAP profit that exceeded Wall Street expectations. Management hig... 
Via StockStory
Topics Earnings
News headline image
3 Small-Cap Stocks with Open Questions
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
Progyny Q1 Earnings Call Highlights ↗
Progyny (NASDAQ:PGNY) reported what management called a strong start to 2026, with first-quarter revenue reaching a record level and profitability exceeding expectations amid continued investments in... 
Via MarketBeat
Topics Earnings
News headline image
Why Is Progyny (PGNY) Stock Soaring Today
What Happened? Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 17.5% in the afternoon session after the company reported first-quarter 2026... 
Via StockStory
News headline image
Progyny (PGNY) Q1 2026 Earnings Call Transcript ↗
Progyny (PGNY) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Progyny’s (NASDAQ:PGNY) Q1 CY2026 Sales Beat Estimates, Stock Soars
Fertility benefits company Progyny (NASDAQ:PGNY) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 1.4% year on year to $328.5... 
Via StockStory
Topics Earnings
News headline image
Progyny, Inc. Announces First Quarter 2026 Results
From Progyny, Inc.
Via GlobeNewswire
News headline image
Progyny (PGNY) Q1 Earnings Report Preview: What To Look For
Fertility benefits company Progyny (NASDAQ:PGNY) will be reporting results this Thursday after the bell. Here’s what to expect. Progyny beat analysts’ revenu... 
Via StockStory
Topics Artificial Intelligence
News headline image
Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
From Progyny, Inc.
Via GlobeNewswire
News headline image
Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan
First-of-its-kind plan expands access to comprehensive, outcomes-based family building and women’s health care with predictable costs for small U.S. employers 
From Progyny, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >